LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Acquisition Escient Pharmaceuticals was recently acquired by Incyte for $750 million. This change can potentially lead to new collaborations and sales opportunities with Incyte's network and resources.

Strategic Investment Forge Life Science Partners made a significant investment of $120 million into Escient Pharmaceuticals. This injection of funds can support further research and development, creating opportunities for partnerships or sales of novel therapeutics.

Focus on Pruritus Treatment Escient Pharmaceuticals is developing MRGPRX4 antagonist for cholestatic pruritus treatment. The innovative approach in addressing specific medical conditions opens avenues for sales partnerships with healthcare providers and institutions in need of such therapies.

Series C Financing Escient Pharmaceuticals secured $120 million in Series C financing. This financial backing can fuel expansion efforts and provide opportunities for sales growth and market penetration in the biotechnology research industry.

Competitive Landscape Escient Pharmaceuticals operates in a competitive landscape with companies like Relay Therapeutics, Kronos Bio, and Kymera Therapeutics. Analyzing strategies of similar companies can aid in identifying sales opportunities and positioning Escient effectively in the market.

Similar companies to Escient Pharmaceuticals

Escient Pharmaceuticals Tech Stack

Escient Pharmaceuticals uses 8 technology products and services including Google Analytics, Google Font API, Twitter Emoji (Twemoji), and more. Explore Escient Pharmaceuticals's tech stack below.

  • Google Analytics
    Analytics
  • Google Font API
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Open Graph
    Miscellaneous
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • USPS
    Transportation And Fleet Management
  • Nginx
    Web Servers

Media & News

Escient Pharmaceuticals's Email Address Formats

Escient Pharmaceuticals uses at least 1 format(s):
Escient Pharmaceuticals Email FormatsExamplePercentage
FLast@escientpharma.comJDoe@escientpharma.com
48%
Last@escientpharma.comDoe@escientpharma.com
2%
FLast@escientpharma.comJDoe@escientpharma.com
48%
Last@escientpharma.comDoe@escientpharma.com
2%

Frequently Asked Questions

Where is Escient Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Escient Pharmaceuticals's main headquarters is located at 10578 Science Center Drive Suite 250 San Diego, CA 92121 US. The company has employees across 2 continents, including North AmericaEurope.

What is Escient Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Escient Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Escient Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Escient Pharmaceuticals's official website is escientpharma.com and has social profiles on LinkedIn.

How much revenue does Escient Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of August 2024, Escient Pharmaceuticals's annual revenue reached $7.5M.

What is Escient Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Escient Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Escient Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of August 2024, Escient Pharmaceuticals has approximately 57 employees across 2 continents, including North AmericaEurope. Key team members include Chief Financial Officer: A. M.Vice President Regulatory Affairs: J. P.Senior Director, Head Of Business Development: G. B.. Explore Escient Pharmaceuticals's employee directory with LeadIQ.

What industry does Escient Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Escient Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Escient Pharmaceuticals use?

Minus sign iconPlus sign icon
Escient Pharmaceuticals's tech stack includes Google AnalyticsGoogle Font APITwitter Emoji (Twemoji)Open GraphPHPYoast SEOUSPSNginx.

What is Escient Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Escient Pharmaceuticals's email format typically follows the pattern of . Find more Escient Pharmaceuticals email formats with LeadIQ.

How much funding has Escient Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of August 2024, Escient Pharmaceuticals has raised $120M in funding. The last funding round occurred on Nov 28, 2022 for $120M.

When was Escient Pharmaceuticals founded?

Minus sign iconPlus sign icon
Escient Pharmaceuticals was founded in 2018.
Escient Pharmaceuticals

Escient Pharmaceuticals

Biotechnology ResearchCalifornia, United States51-200 Employees

Escient is a clinical-stage pharmaceutical company focused on developing novel therapeutics to address a broad range of neurosensory-inflammatory diseases. Our pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for the treatment of various mast cell-mediated disorders and MRGPRX4 for cholestatic pruritus. Based in San Diego, California, Escient is led by an experienced team with specific expertise in GPCR drug discovery and development and funded by top-tier life science investors.

Section iconCompany Overview

Headquarters
10578 Science Center Drive Suite 250 San Diego, CA 92121 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $120M

    Escient Pharmaceuticals has raised a total of $120M of funding over 3 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $120M.

  • $10M

    Escient Pharmaceuticals's revenue is in the range of $10M

Section iconFunding & Financials

  • $120M

    Escient Pharmaceuticals has raised a total of $120M of funding over 3 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $120M.

  • $10M

    Escient Pharmaceuticals's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.